-
Digoxin Workflows for Cardiac and Antiviral Research
2026-08-17
Digoxin enables mechanism-focused studies that connect Na+/K+-ATPase inhibition with cardiac contractility modulation and cell-specific antiviral phenotypes. This practical guide covers solution preparation, dose-response design, translational animal workflows, and troubleshooting for cardiac and chikungunya research.
-
NHS-Biotin: Mechanism, Workflow, and Limits
2026-08-16
NHS-Biotin, also called N-hydroxysuccinimido biotin, is an amine-reactive reagent for covalent labeling of antibodies, proteins, and other primary amine-containing biomolecules. Its short, uncharged spacer supports low-steric-hindrance detection and membrane-permeable labeling, while its water insolubility requires controlled preparation in DMSO or DMF.
-
AICAR and AMPK: From Energy Sensing to Airway Inflammation
2026-08-15
AICAR offers translational researchers a practical way to connect cellular energy sensing with macrophage polarization and airway inflammation. This article examines the AMPK–JAK2/STAT3 axis, interprets recent obesity-related asthma findings, and outlines a rigorous strategy for using AICAR in metabolic and inflammatory research.
-
AI-10-49 Workflow for CBFβ-SMMHC Inhibition
2026-08-14
AI-10-49 enables mechanism-led acute myeloid leukemia research by connecting CBFβ-SMMHC–RUNX1 dissociation with transcriptional, survival, and chromatin readouts. This workflow helps researchers move from target engagement in ME-1 cells to optimized proliferation assays, chromatin immunoprecipitation, and in vivo leukemia mouse model studies.
-
Protease Inhibitor Cocktail EDTA-Free for TCR Studies
2026-08-14
Mechanistic immunology increasingly depends on preserving fragile receptor complexes, phosphorylation states, and native protein architecture long enough to distinguish biology from sample-preparation artifacts. The 2025 Cell study on LAG-3/TCR proximity illustrates this challenge: spatial organization around CD3ε and Lck is central to T cell suppression. This article translates that insight into practical protein-handling strategy, showing where an EDTA-free Protease Inhibitor Cocktail can strengthen Western blotting, co-immunoprecipitation, kinase assays, and other translational workflows while clarifying its limitations.
-
Nde1 Links Mitochondrial Respiration to Cell Death
2026-08-13
Saladi et al. show that yeast Nde1 is not only an NADH dehydrogenase but also a mitochondrial surface sensor that integrates respiratory status with proteostatic control. Using isotope-labeling mass spectrometry and complementary cell-biological experiments, the study connects Nde1 turnover, membrane topology, and selective elimination of respiratory-compromised cells.
-
VX-661 F508del CFTR Corrector: Assay Guide
2026-08-13
This scenario-based guide explains how VX-661 (F508del CFTR corrector), SKU A2664, can support more interpretable CFTR trafficking, viability, and chloride-channel experiments. It covers controls, dosing, compound handling, combination studies, and vendor-selection criteria grounded in the available product information and recent CFTR proteostasis research.
-
Aprotinin in Protease and RBC Membrane Workflows
2026-08-12
Aprotinin provides reversible control of trypsin, plasmin, and kallikrein for fibrinolysis, inflammation, and cardiovascular surgery research. This practical guide connects protease inhibition with red blood cell membrane studies while separating validated findings from assay-specific recommendations.
-
GDC-0994 ERK1/2 Inhibitor Workflows
2026-08-12
GDC-0994 offers a precise way to interrogate ERK-driven tumor biology and estrogen-associated cholestatic injury in complementary models. This workflow-focused guide covers assay design, pathway readouts, dose handling, rescue experiments, and troubleshooting for reproducible ERK1/2 inhibition.
-
Radiotherapy, PD-1/TIGIT Blockade, and Immune Memory
2026-08-11
The 2025 Cancer Letters study shows that radiotherapy combined with PD-1 and TIGIT blockade can coordinate local tumor control, abscopal responses, and durable immune memory through CD8+ T cells. Its integrated mouse-model, single-cell, cytokine, and adoptive-transfer analyses identify activated M1 macrophages and CD8+ T-cell cooperation as important components of the response.
-
NHS-Biotin for Protein Labeling Workflows
2026-08-11
NHS-Biotin converts accessible primary amines into stable biotin tags for antibody detection, affinity purification, and intracellular protein studies. This practical guide shows how to integrate amine-reactive labeling with emerging multimeric nanobody assays while avoiding overlabeling, hydrolysis, and misleading avidity effects.
-
Forskolin in cAMP–Calcium Signaling Assays
2026-08-10
Forskolin is more than an adenylate cyclase activator: it can serve as a causal probe of cAMP-dependent calcium-channel regulation. This guide translates recent hippocampal-neuron findings into assay-design decisions while distinguishing mechanistic evidence from broader application models.
-
Amikacin (BAY416651) Research Guide
2026-08-09
Amikacin (BAY416651) is a semi-synthetic aminoglycoside and bacterial protein synthesis inhibitor used in antibiotic resistance research. Its 30S-ribosome activity, relative resistance to many aminoglycoside-modifying enzymes, and documented targeted-delivery study support applications in bacterial and mycobacterial research, while product-handling limits remain important.
-
Lipo3K Transfection Reagent for Ferroptosis Studies
2026-08-08
Discover how the Lipo3K Transfection Reagent can support causal studies of the OTUD3–SLC7A11 ferroptosis pathway in clear cell renal cell carcinoma. This article connects low-toxicity nucleic acid delivery with experimental design, controls, and assay interpretation for drug-resistance research.
-
2-Thio-dCTP Workflows for DNA and Chromatin
2026-08-07
Use 2-Thio-dCTP as a controlled DNA polymerase substrate for probing nucleotide selectivity, site-specific DNA modification, and DNA–protein interactions. This practical guide connects nucleotide-incorporation assays with the SCP4–H3T3 chromosome-stability pathway while clearly separating established findings from exploratory chromatin applications.